O&G Vivas · Antenatal care — medical disorders of pregnancy
SLE and antiphospholipid syndrome in pregnancy — structured oral station (12 minutes)
FRANZCOG oral-format station on SLE with lupus nephritis and probable APS planning pregnancy: pre-conception optimisation, the hydroxychloroquine case, the LMWH ladder, neonatal lupus surveillance, and communication. Scored against the eight published RANZCOG oral domains.
On this page & tools
Target exams
Station format
4 minutes reading, 12 minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply: history and examination; investigations and interpreting results; treatment/management; clinical knowledge; complex, urgent or unusual clinical presentations; rapport; respect; communication skills. You are marked on how you behave as much as what you know.[3]
Reveal the examiner script and model responses
Opening prompt — "Take me through how you would plan this woman's next pregnancy."
Model response — say it in this order: [3][12]
- "This is a high-risk pregnancy that needs planning before conception. The two leading risks are another pregnancy loss and a flare of her lupus nephritis, plus the neonatal lupus risk from her anti-Ro and anti-La antibodies."
- "First I would aim for at least six months of quiescent disease before conception, with stable renal function — her creatinine and proteinuria should be at their baseline."
- "I would switch her teratogenic medications pre-conception: mycophenolate to azathioprine or a calcineurin inhibitor, ramipril to labetalol or nifedipine, and stop the combined oral contraceptive."
- "I would continue hydroxychloroquine 400 mg daily — both EULAR and ACR strongly recommend continuation, because it lowers flare, pregnancy loss, preeclampsia and recurrent congenital heart block."
- "I would start aspirin 75-150 mg from early pregnancy, confirm her aPL status with a repeat panel at least 12 weeks apart, and plan serial fetal echocardiography from 16-18 weeks because she is anti-Ro/La positive."[3][12]
Examiner is listening for: pre-conception planning, teratogenic drug switch, hydroxychloroquine continuation, APS persistence rule, neonatal lupus surveillance. [1][9]
Probe 1 — "She asks why she cannot stay on mycophenolate, which has kept her well. What do you say?"
- "Mycophenolate is teratogenic — major malformations including external ear, cardiac, and limb anomalies. It must be switched before conception, ideally six weeks before, to azathioprine or a calcineurin inhibitor such as tacrolimus, which are effective for lupus nephritis and pregnancy-compatible."
- "I would coordinate the switch with her rheumatologist and nephrologist, and confirm disease quiescence on the new regimen before she conceives."
- "I would also check she is not on warfarin, an ACE inhibitor or ARB, methotrexate, cyclophosphamide, or leflunomide — each is teratogenic."[3][12]
Probe 2 — "Her lupus anticoagulant was positive once, six months ago. Does she have antiphospholipid syndrome?"
- "Not yet on a single positive antibody. The revised Sapporo criteria require one clinical criterion plus one laboratory criterion, with the antibody positive on two occasions at least 12 weeks apart within 5 years."
- "Her second-trimester loss at 18 weeks may satisfy the clinical criterion only if morphologically normal and otherwise unexplained, or if there was severe preeclampsia or placental insufficiency before 34 weeks; I would clarify the detail of that loss."
- "I would repeat the full aPL panel — lupus anticoagulant, anticardiolipin IgG/IgM, anti-β2-glycoprotein-I IgG/IgM — at least 12 weeks after the first positive, and classify APS only if she meets the criteria."
- "If confirmed, the pregnancy regimen is aspirin plus prophylactic LMWH from a positive pregnancy test, with HCQ added; six weeks of postpartum LMWH."[1][2]
Probe 3 — "She becomes pregnant. At 22 weeks she presents with hypertension, proteinuria and a low complement. Is this a flare or preeclampsia, and what do you do?"
- "Falling complement with rising dsDNA, active urinary sediment (red cell casts) and a normal PlGF point to a lupus nephritis flare rather than preeclampsia — preeclampsia typically has normal complement, stable dsDNA, bland sediment and a low PlGF."
- "I admit her, control her blood pressure with labetalol or nifedipine to under 140/90, escalate immunosuppression with pregnancy-safe agents (prednisolone, tacrolimus, azathioprine), continue hydroxychloroquine, and surveil with continuous CTG, daily renal function and serial growth scans."
- "I involve the renal and rheumatology teams immediately; delivery is for maternal or fetal compromise or deteriorating renal function, not for the flare per se."[6][12]
Probe 4 — "At her routine 24-week CTG the fetal heart rate is 75 with a dissociated rhythm. What is the diagnosis and what is your plan?"
- "This is congenital heart block in a known anti-Ro/La-positive mother — second or third degree. I confirm with fetal echocardiography, refer to fetal medicine and paediatric cardiology, and admit for monitoring."
- "Fluorinated steroids (dexamethasone) are considered for second-degree or inflammatory block, though they do not reverse established third-degree block; most surviving children need a pacemaker."
- "For her next pregnancy, hydroxychloroquine 400 mg started before 10 weeks reduces the recurrence rate from about 18% to 7-8%."[8][9]
Probe 5 — "She is frightened about her fertility and the long-term outlook. What do you say?"
This is a scored communication domain. Demonstrate it out loud: [3]
- Sit down, use her name, acknowledge the fear: "I can see this is a lot to take in. Let me explain what we know and what we will do together."
- "Your lupus can be managed through pregnancy when it is planned and your disease is quiet. Your fertility is not affected by lupus itself."
- "We will re-baseline your kidney function after each pregnancy and work with your nephrologist to slow any long-term change. Your contraception needs to be oestrogen-free because of the antiphospholipid antibody — I will arrange that today."
- Avoid jargon, allocate a named support person, and commit to a written plan and a debrief.[3]
Probe 6 — "Tell me about her contraceptive options going forward."
- "Oestrogen-containing combined hormonal contraception is contraindicated in antiphospholipid syndrome — it is prothrombotic. Her options are progestogen-only: the progestogen-only pill, the etonogestrel subdermal implant, or a levonorgestrel intrauterine system."
- "A copper intrauterine device is also acceptable if she prefers non-hormonal methods."[2][3]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship atlas.
References7Show ledgerHide ledger
- [1]Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost, 2006.PMID 16420554
- [2]Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults Ann Rheum Dis, 2019.PMID 31092409
- [3]Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases Arthritis Rheumatol, 2020.PMID 32090480
- [6]Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study Am J Obstet Gynecol, 2016.PMID 26432463
- [8]Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, Khamashta MA, Kim MY, Saxena A, Friedman D, Llanos C, Piette JC, Buyon JP Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus Circulation, 2012.PMID 22626746
- [9]Izmirly P, Kim M, Friedman DM, Costedoat-Chalumeau N, Clancy R, Copel JA, Phoon CKL, Cuneo BF, Cohen RE, Robins K, Masson M, Wainwright BJ, Zahr N, Saxena A, Buyon JP Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers J Am Coll Cardiol, 2020.PMID 32674792
- [12]Hladunewich MA, Bramham K, Jim B, et al. Managing glomerular disease in pregnancy Nephrol Dial Transplant, 2017.PMID 28391337